-+ 0.00%
-+ 0.00%
-+ 0.00%

MOLECULAR PARTNERS AG - MP0317 SHOWED FAVORABLE SAFETY UP TO HIGHEST DOSE AND SUITABILITY FOR WEEKLY OR THREE-WEEK DOSING

Reuters·05/01/2026 11:00:49

Please log in to view news